Paradigm Biocapital Advisors LP Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$378.2B
Holdings
25
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A/S | 321,621 | $37.7B | 9.98% | |
| 2 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 966,827 | $33.5B | 8.86% | |
| 3 | ARVNARVINAS INC | 491,333 | $33.1B | 8.74% | |
| 4 | LEGNLEGEND BIOTECH CORP | 831,728 | $30.2B | 7.99% | |
| 5 | —SIERRA ONCOLOGY INC | 771,314 | $24.7B | 6.54% | |
| 6 | VRDNVIRIDIAN THERAPEUTICS INC | 1,256,051 | $23.2B | 6.14% | |
| 7 | INCYINCYTE CORP | 234,419 | $18.6B | 4.92% | |
| 8 | OPHTEURIVERIC BIO INC | 910,416 | $15.3B | 4.05% | |
| 9 | IOVAIOVANCE BIOTHERAPEUTICS INC | 907,428 | $15.1B | 4.00% | |
| 10 | IMCRIMMUNOCORE HLDGS PLC | 499,190 | $14.9B | 3.95% | |
| 11 | HZNPHORIZON THERAPEUTICS PUB L | 136,243 | $14.3B | 3.79% | |
| 12 | UTHUNITED THERAPEUTICS CORP DEL | 75,635 | $13.6B | 3.59% | |
| 13 | ZNTLZENTALIS PHARMACEUTICALS INC | 287,577 | $13.3B | 3.51% | |
| 14 | SNDXSYNDAX PHARMACEUTICALS INC | 701,356 | $12.2B | 3.22% | |
| 15 | CCCCC4 THERAPEUTICS INC | 499,496 | $12.1B | 3.20% | |
| 16 | OYSTOYSTER PT PHARMA INC | 987,698 | $11.5B | 3.04% | |
| 17 | PRTAPROTHENA CORP PLC | 267,946 | $9.8B | 2.59% | |
| 18 | KYMRKYMERA THERAPEUTICS INC | 227,034 | $9.6B | 2.54% | |
| 19 | MRTXEURMIRATI THERAPEUTICS INC | 98,383 | $8.1B | 2.14% | |
| 20 | MRUSMERUS N V | 249,738 | $6.6B | 1.75% | |
| 21 | VORVOR BIOPHARMA INC | 894,404 | $5.4B | 1.43% | |
| 22 | ESPRESPERION THERAPEUTICS INC NE | 1,157,246 | $5.4B | 1.42% | |
| 23 | FULCFULCRUM THERAPEUTICS INC | 212,961 | $5.0B | 1.33% | |
| 24 | NVLSEURALPINE IMMUNE SCIENCES INC | 336,229 | $3.0B | 0.80% | |
| 25 | GRCLGRACELL BIOTECHNOLOGIES INC | 783,445 | $1.8B | 0.48% |